The Role of PI3-Kinase Signaling Pathway in Defining Sensitivity and Resistance

$383,423P50FY2008CANIH

Dana-Farber Cancer Inst, Boston MA

Investigators

Jeffrey A Meyerhardtcontact

Linked publications, trials & patents

Paper 39574772 Paper 39484452 Paper 39388288 Paper 39345481 Paper 39345400 Paper 39326063 Paper 39239102 Paper 39227743 Paper 39134413 Paper 39122726 Paper 39107837 Paper 39026794 Paper 39018351 Paper 39005266 Paper 38991060 Paper 38975874 Paper 38948759 Paper 38861327 Paper 38816352 Paper 38802576 Paper 38758104 Paper 38714664 Paper 38437671 Paper 38381401 Paper 38354702 Paper 38345769 Paper 38319287 Paper 38272561 Paper 38261044 Paper 38260999 Paper 38236605 Paper 38123998 Paper 38040420 Paper 38014256 Paper 37961410 Paper 37843855 Paper 37819936 Paper 37733830 Paper 37729870 Paper 37695631 Paper 37561981 Paper 37463915 Paper 37463056 Paper 37156936 Paper 37117188 Paper 37053534 Paper 37040087 Paper 37031062 Paper 36914816 Paper 36914658 Paper 36894939 Paper 36854058 Paper 36763374 Paper 36709596 Paper 36702949 Paper 36653422 Paper 36602796 Paper 36551707 Paper 36399782 Paper 36202931 Paper 36190545 Paper 36129461 Paper 36056177 Paper 35831509 Paper 35771492 Paper 35760086 Paper 35732135 Paper 35715632 Paper 35641198 Paper 35459940 Paper 35420673 Paper 35398288 Paper 35390065 Paper 35226770 Paper 35074047 Paper 35032765 Paper 35032257 Paper 35026030 Paper 34996545 Paper 34969824 Paper 34937729 Paper 34890551 Paper 34857594 Paper 34848557 Paper 34705075 Paper 34671163 Paper 34653818 Paper 34511196 Paper 34508353 Paper 34450029 Paper 34428095 Paper 34377593 Paper 34293086 Paper 34285063 Paper 34267328 Paper 34264325 Trial NCT03060720 Trial NCT02584244 Trial NCT02172651 Trial NCT02079740

View original record on NIH RePORTER →